Author: admin

Systemic Sclerosis Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Systemic Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the Systemic Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Systemic Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Systemic Sclerosis Pipeline. Dive into DelveInsight’s comprehensive report today! @ Systemic Sclerosis Pipeline Outlook

Key Takeaways from the Systemic Sclerosis Pipeline Report

  • In June 2025, Novartis Pharmaceuticals announced a study is to evaluate the efficacy, safety and tolerability of rapcabtagene autoleucel (administered once following lymphodepletion) in participants with severe refractory diffuse cutaneous systemic sclerosis relative to rituximab.
  • In June 2025, GlaxoSmithKline conducted a study of an ongoing randomized controlled clinical study 218224 (Parent Study). The OLE study will describe how well tolerated belimumab will be long term, and whether it might continue to slow progression of lung function decline, slow overall disease progression and improve quality of life.
  • DelveInsight’s Systemic Sclerosis Pipeline report depicts a robust space with 50+ active players working to develop 50+ pipeline therapies for Systemic Sclerosis treatment.
  • The leading Systemic Sclerosis Companies such as Eicos Sciences, Beijing Continent Pharmaceutical, Kyowa Kirin, Cytori Therapeutics, Corbus Pharmaceuticals, Zenyaku Kogyo, Sanofi, Bayer, ASKA Pharmaceutical, Emerald Health Pharmaceuticals, United Therapeutics, Cumberland Pharmaceuticals, ILTOO Pharma, Horizon Pharmaceuticals, Janssen Biotech, Gesynta Pharma, Certa Therapeutics, Pfizer, Vicore Pharma, Seagen, CSL Behring, arGentis Pharmaceuticals, Mitsubishi Tanabe Pharma, Kadmon Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb, Camurus, Regeneron Pharmaceuticals, Castle Creek Biosciences, Talaris Therapeutics, Viela Bio, Formation Biologics, Horizon Therapeutics, Chemomab Therapeutics, AnaMar, Atlantic Healthcare, D&D Pharmatech, Acceleron Pharma, Riptide Bioscience, Timber Pharmaceuticals, Tvardi Therapeutics, Accuitis Pharmaceuticals, AKL Research and Development, iBio, Blade Therapeutics, Cantargia, BriaCell Therapeutics, Leadiant Biosciences and others.
  • Promising Systemic Sclerosis Pipeline Therapies such as Divozilimab, Avenciguat (BI 685509), Nintedanib, GSK2330811, Riociguat (Adempas, BAY63-2521), Bosentan, Imatinib mesylate, Belimumab, Rituximab, and others.

Stay ahead with the most recent pipeline outlook for Systemic Sclerosis. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Systemic Sclerosis Treatment Drugs

Systemic Sclerosis Emerging Drugs Profile

  • Iloprost: Eicos Sciences

Iloprost is a stable analogue of PGI2 and a potent prostacyclin (IP) receptor agonist. By mimicking PGI2, it is a vasodilator and inhibitor of platelet activation and fibrosis. Iloprost stimulates generation of cAMP by binding to the IP receptor, thereby affecting phospholipase activity and cytosolic calcium levels in platelets, fibroblasts, and endothelial cells. It is a potent vasodilator and platelet inhibitor with anti-inflammatory and anti-fibrotic effects being developed and investigated in Phase III stage of development for the treatment of digital ischemic episodes in people with Systemic Sclerosis (SSc).

  • ECCS 50: Cytori therapeutics

ECCS-50 (Cytori stem cell therapy) is a new treatment intended for the treatment of moderate to severe hand problems in people with scleroderma. It involves taking stem cells (a cell with the potential to become any cell type) from patient’s fat tissue and reinjecting these cells into the hands. ECCS 50 are adipose derived stem and regenerative cells (ADRCs) taken from the patient’s own tissue and prepared using Cytori’s cellulation system before administration. ADRCs can be used to repair and regenerate a range of damaged or diseased tissue types by differentiation of the ASRCs along the specific cell lineage, thereby replacing the damaged or missing tissue.

  • Lenabasum (JBT-101): Corbus Pharmaceuticals

Lenabasum is a novel, oral, small molecule designed to provide an alternative to immunosuppressive treatments for inflammatory or fibrotic diseases. Lenabasum binds to and activates the cannabinoid receptor type 2 (CB2), which is preferentially expressed on activated immune cells, to resolve inflammation and limit fibrosis. Data from animal models and human clinical studies suggest that lenabasum can reduce expression of genes and proteins involved in inflammation and fibrosis. In clinical testing to date, lenabasum has acceptable safety and tolerability profiles without evidence of immunosuppression.

  • EHP-101: Emerald Health Pharmaceuticals

EHP-101 is an oral formulation of VCE-004.8, a synthetic aminoquinone derivative of CBD with dual peroxisome proliferator-activated receptor gamma (PPARγ) and cannabinoid receptor type 2 (CB2) agonist activity. Both receptors are therapeutic targets for SSc. EHP-101 also modulates the hypoxia inducible factor (HIF) pathway, expanding the rationale for its development as a novel SSc drug. It is currently in phase II stage of development and is being developed by Emerald Health Pharmaceuticals.

The Systemic Sclerosis Pipeline Report Provides Insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Systemic Sclerosis with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Systemic Sclerosis Treatment.
  • Systemic Sclerosis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Systemic Sclerosis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Systemic Sclerosis market

Explore groundbreaking therapies and clinical trials in the Systemic Sclerosis Marketed and Pipeline Drugs. Access DelveInsight’s detailed report now! @ New Systemic Sclerosis Drugs

Systemic Sclerosis Companies

Eicos Sciences, Beijing Continent Pharmaceutical, Kyowa Kirin, Cytori Therapeutics, Corbus Pharmaceuticals, Zenyaku Kogyo, Sanofi, Bayer, ASKA Pharmaceutical, Emerald Health Pharmaceuticals, United Therapeutics, Cumberland Pharmaceuticals, ILTOO Pharma, Horizon Pharmaceuticals, Janssen Biotech, Gesynta Pharma, Certa Therapeutics, Pfizer, Vicore Pharma, Seagen, CSL Behring, arGentis Pharmaceuticals, Mitsubishi Tanabe Pharma, Kadmon Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb, Camurus, Regeneron Pharmaceuticals, Castle Creek Biosciences, Talaris Therapeutics, Viela Bio, Formation Biologics, Horizon Therapeutics, Chemomab Therapeutics, AnaMar, Atlantic Healthcare, D&D Pharmatech, Acceleron Pharma, Riptide Bioscience, Timber Pharmaceuticals, Tvardi Therapeutics, Accuitis Pharmaceuticals, AKL Research and Development, iBio, Blade Therapeutics, Cantargia, BriaCell Therapeutics, Leadiant Biosciences and others.

Systemic Sclerosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical.
  • Molecule Type

Systemic Sclerosis Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

Unveil the future of Systemic Sclerosis Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Systemic Sclerosis Market Drivers and Barriers

Scope of the Systemic Sclerosis Pipeline Report

  • Coverage- Global
  • Systemic Sclerosis Companies- Eicos Sciences, Beijing Continent Pharmaceutical, Kyowa Kirin, Cytori Therapeutics, Corbus Pharmaceuticals, Zenyaku Kogyo, Sanofi, Bayer, ASKA Pharmaceutical, Emerald Health Pharmaceuticals, United Therapeutics, Cumberland Pharmaceuticals, ILTOO Pharma, Horizon Pharmaceuticals, Janssen Biotech, Gesynta Pharma, Certa Therapeutics, Pfizer, Vicore Pharma, Seagen, CSL Behring, arGentis Pharmaceuticals, Mitsubishi Tanabe Pharma, Kadmon Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb, Camurus, Regeneron Pharmaceuticals, Castle Creek Biosciences, Talaris Therapeutics, Viela Bio, Formation Biologics, Horizon Therapeutics, Chemomab Therapeutics, AnaMar, Atlantic Healthcare, D&D Pharmatech, Acceleron Pharma, Riptide Bioscience, Timber Pharmaceuticals, Tvardi Therapeutics, Accuitis Pharmaceuticals, AKL Research and Development, iBio, Blade Therapeutics, Cantargia, BriaCell Therapeutics, Leadiant Biosciences and others.
  • Systemic Sclerosis Pipeline Therapies- Divozilimab, Avenciguat (BI 685509), Nintedanib, GSK2330811, Riociguat (Adempas, BAY63-2521), Bosentan, Imatinib mesylate, Belimumab, Rituximab, and others.
  • Systemic Sclerosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Systemic Sclerosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Systemic Sclerosis Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Systemic Sclerosis Companies, Key Products and Unmet Needs

Table of Content

  1. Introduction
  2. Executive Summary
  3. Systemic Sclerosis: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Iloprost: Eicos Sciences
  8. Drug profiles in the detailed report…..
  9. Mid Stage Products (Phase II)
  10. EHP-101: Emerald Health Pharmaceuticals
  11. Drug profiles in the detailed report…..
  12. Early stage products (Phase I)
  13. VIB7734: Viela Bio
  14. Drug profiles in the detailed report…..
  15. Inactive Products
  16. Systemic Sclerosis Key Companies
  17. Systemic Sclerosis Key Products
  18. Systemic Sclerosis- Unmet Needs
  19. Systemic Sclerosis- Market Drivers and Barriers
  20. Systemic Sclerosis- Future Perspectives and Conclusion
  21. Systemic Sclerosis Analyst Views
  22. Systemic Sclerosis Key Companies
  23. 23. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/systemic-sclerosis-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Systemic Sclerosis Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

From Craft to Commerce: Creative Rubber Stamps Says Businesses Are Now Driving Spike in Custom Signature Stamp Sales

Creative Rubber Stamps’ founder, Gary Lay, highlights remote work, personalization, and legal compliances as key drivers.

As small businesses and professionals look for smarter, more efficient ways to handle repetitive paperwork, Creative Rubber Stamps is seeing a significant surge in demand for its self-inking signature stamps.

Recent industry research reported that the global rubber stamp market is on track to grow at a CAGR of 4.05% from 2025 to 2033. This growth is projected to be driven by increased documentation requirements, brand personalization, and the growing need for time-saving innovations. Once considered a niche craft tool, rubber stamps have not only entered the mainstream business world but have become essential business accessories.

According to the founder of Creative Rubber Stamps, Gary Lay, the rise in custom stamp usage among small businesses represents a significant shift in the industry. He explained that custom self-inking signature stamps are quickly replacing the outdated print-sign-scan routine for businesses. Due to their affordability, branding potential, efficiency, and record-keeping benefits, custom signature stamps have become a way for businesses to leave a recognizable, professional mark on every transaction. Many small businesses are now using custom self-inking stamps to sign documents, maintain signature consistency, and speed up their internal operations – all while adding a professional touch.

“We have watched the rubber stamp market evolve over the years, but this shift has been momentous,” said Gary. “More professionals are realizing that they don’t need to go through the tedious printing, signing, and scanning process when they can opt for custom signature stamps that save time, improve accuracy, and add a layer of professionalism.”

Creative Rubber Stamps embraces this growth by sharpening its focus on innovation and customer experience.

One of Creative Rubber Stamps’ competitive advantages is its signature self-inking stamps, which offer clean signatures in ink with a single press. Unlike traditional stamps that require a separate ink pad, the self-inking models automatically re-ink, allowing for hundreds of crisp, clean impressions before needing a refill. Beyond the speed and convenience, these signature stamps also help people maintain consistency across documents and reduce the chances of signature errors, smudges, and forgery.

To ensure quality, Creative Rubber Stamps carries the best customizable stamp brands in the market, Trodat, a brand that is recognized as the world’s top manufacturer of self-inking stamp cases. All customers have to do on Creative Rubber Stamps’ site is select the Trodat brand stamp they want for their custom signature. Creative Rubber Stamps also ensures that each signature stamp is laser engraved in rubber for a crisp, cleaner image. Moreover, the company offers a preview function for clients after uploading their artwork, which allows them to visualize how it will look on the finished stamp. This also gives them an opportunity to make design and size adjustments before placing their order. With custom stamps starting at $20, Creative Rubber Stamps has established itself as the go-to custom stamps.

Creative Rubber Stamps has seen the spike in custom signature sales come from the legal, healthcare, and financial sectors, where document approval is a constant task. With thousands of satisfied customers, infinite customization options, and a vast product catalog that includes address stamps, notary stamps, logo stamps, monogram stamps, and date stamps, Creative Rubber Stamps has established itself as a staple vendor for small businesses seeking speed, efficiency, and polish. The company, which boasts over 30 years of design and stamp experience, continues to carve out its space in the growing market by offering professionals and small businesses access to customizable signature stamps that they can instantly preview.

Gary reaffirmed that he and his team are excited to continue helping time-starved professionals secure self-inking signature stamps. “We love how versatile stamps are. I believe that is why they are catching on so quickly, especially for small businesses,” he said. “My team and I are excited to see something we are so passionate about become widely adopted by professionals and businesses and commit to continuing to help our customers create custom stamps that are uniquely theirs.”

He concluded by saying that the company’s growth has been driven by its dedication to serving clients and keeping pace with market trends. “Our growth has come from listening to customers and staying up to date on market trends. We are not just selling stamps; we are giving people tools that make workdays easier.”

Visit Creative Rubber Stamps to explore its full collection of custom rubber stamps.

Media Contact
Company Name: Creative Rubber Stamps
Contact Person: Gary Lay
Email: Send Email
Country: United States
Website: https://creativerubberstamps.com/collections/signature-stamps

Vision Restored: Dr. Chris Palmer and Patient Ken Nelson Inspire Viewers on “Twin Cities Live” with Breakthrough Eyewear

Low Vision Glasses Give Ken Nelson His Sight Back: Dr. Palmer Featured on “Twin Cities Live” for Life-Changing Work.

St. Paul, MN – A powerful story of perseverance and technological innovation took center stage on KSTP Channel 5’s Twin Cities Live as Dr. Chris Palmer of Low Vision Restoration appeared with patient Ken Nelson, a resident of Isanti, MN, to share how specialized glasses changed Ken’s life.

Ken suffers from a rare genetic form of macular degeneration, a progressive eye condition that severely impaired his ability to see faces or carry out everyday activities. That changed dramatically when he was fitted with bioptic telescope glasses, an advanced solution designed for people with permanent vision loss.

“The center of my vision wasn’t just black, it was blank,” Ken told viewers. “The first time I put on these glasses, I said, ‘Oh my God, I can see your face!’ It was amazing. These glasses have helped me do better in life than I was four or five years ago.”

Bioptic telescope glasses are customized devices that embed miniature telescopes into prescription lenses, allowing users to focus on specific tasks that require sharper vision—like reading, recognizing faces, and even driving. Dr. Palmer, one of about 50 Fellows in the International Academy of Low Vision Specialists (IALVS), is uniquely trained to evaluate and fit patients with this type of technology.

“We use magnification to make things bigger, closer, and easier to see, so people can continue doing what they love,” Dr. Palmer explained during the segment. “For many, that includes being able to drive again and regain their independence.”

Dr. Palmer sees patients from across the Twin Cities and throughout Minnesota, providing hope to those with macular degeneration, glaucoma, diabetic retinopathy, and other vision impairments. Each patient undergoes a personalized evaluation to determine whether bioptic or other specialized eyewear can restore functional sight.

The Twin Cities Live segment gave viewers a moving and firsthand look at how cutting-edge optics are transforming lives. Ken’s emotional testimony struck a chord with many.

“Now I can see everywhere,” Ken said. “I’m happy.”

Airing weekdays on KSTP Channel 5, Twin Cities Live highlights inspiring stories and practical solutions that make a real difference in viewers’ lives. Dr. Palmer’s work and Ken’s story exemplify how compassion, science, and innovation can change what’s possible.

To watch the full segment and learn more about Dr. Palmer’s work, visit their website.

About Low Vision Restoration:

Led by Dr. Chris Palmer, Low Vision Restoration provides customized magnification solutions for people with permanent vision loss. Dr. Palmer is a Fellow of the International Academy of Low Vision Specialists and is recognized nationally for helping individuals regain their independence.

Media Contact
Company Name: Low Vision Restoration, LLC
Contact Person: Dr. Chris Palmer
Email: Send Email
Phone: +1 612-729-3030
Country: United States
Website: https://lowvisionofmn.com/twin-cities-live

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vision Restored: Dr. Chris Palmer and Patient Ken Nelson Inspire Viewers on “Twin Cities Live” with Breakthrough Eyewear

Bispecific and Trispecific Antibodies Market Anticipated to Witness Remarkable Expansion by 2035, Says DelveInsight | Leading Players Include Akeso, Summit Therapeutics, Zymeworks, BeiGene, more

“Bispecific and Trispecific Antibodies Market”
Bispecific and Trispecific Antibodies companies include AbbVie/Genmab, Roche/Biogen, Pfizer, Amgen, Akeso Biopharma, Summit Therapeutics, SystImmune, Biotheus, Alphamab, Sichuan Baili Pharmaceutical, Regeneron, Merus, Jazz Pharma/Zymeworks, Aurigene Oncology, and others.

DelveInsight’s latest report, “Bispecifics/Trispecifics Market Forecast and Competitive Landscape 2035,” provides a comprehensive analysis of the current and future landscape of the bispecifics/trispecifics market. The report offers in-depth epidemiological trends, market dynamics, and emerging treatment approaches, empowering stakeholders with the insights needed to navigate evolving challenges and seize upcoming opportunities in this rapidly advancing field. With increasing awareness, research breakthroughs, and a strong pipeline, the bispecifics/trispecifics market is poised for exponential growth through 2035.

The bispecifics/trispecifics market is driven by the need for targeted treatments in cancers like ALL, DLBCL, Follicular Lymphoma, Multiple Myeloma, NSCLC, and SCLC. These therapies improve patient outcomes by targeting multiple tumor mechanisms, offering hope for more effective and personalized treatments, and expanding the market in oncology by 2035.

 

Request for sample report @ Bispecifics/Trispecifics Market Forecast

 

Some of the key insights of the Bispecifics/Trispecifics Market Report:

  • In 2023, the bispecific antibodies market in oncology across the 7MM was valued at around USD 690 million and is projected to grow through 2035.
  • In 2023, the U.S. had the largest pool of promising bispecific antibody indications in oncology, followed by EU4 and the UK.
  • DLBCL and Multiple Myeloma had the highest patient pools, while acute lymphocytic leukemia, affecting mainly children, had a smaller pool.
  • By 2035, DLBCL is expected to lead the bispecific antibodies oncology market, reaching approximately USD 4.5 billion, followed by NSCLC and multiple myeloma.
  • By 2035, ELREXFIO is expected to capture the largest share of the multiple myeloma bispecific antibodies market, reaching around USD 1 billion in the 7MM.
  • In March 2025, Sanofi and Dren Bio had entered into a definitive agreement under which Sanofi had agreed to acquire DR-0201, a targeted bispecific myeloid cell engager (MCE) that has shown robust B-cell depletion in pre-clinical and early clinical studies.
  • In November 2024, ZIIHERA received FDA approval for intravenous use in adults with previously treated, unresectable, or metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC), as confirmed by an FDA-approved test. This makes it the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the US.
  • In September 2024, the FDA approved RYBREVANT with chemotherapy (carboplatin and pemetrexed) for adults with advanced or metastatic NSCLC with EGFR exon 19 deletions or L858R mutations, whose disease progressed after EGFR TKI treatment.
  • Emerging therapies for bispecifics/trispecifics include Ivonescimab, Zenocutuzumab, Petosemtamab, Cevostamab, Volrustomig, Rilvegostomig, Lutikizumab, PRV-3279, MEDI-7352, DR-0201, GB263T, CMG1A46, HPN328, and others.
  • Key companies involved in the treatment of bispecifics/trispecifics include AbbVie/Genmab, Roche/Biogen, Pfizer, Amgen, Akeso Biopharma, Summit Therapeutics, SystImmune, Biotheus, Alphamab, Sichuan Baili Pharmaceutical, Regeneron, Merus, Jazz Pharma/Zymeworks, Aurigene Oncology, and others.

 

To know in detail about the bispecifics/trispecifics market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: Bispecifics/Trispecifics Drugs Market

 

Bispecifics/Trispecifics Overview

Bispecific and trispecific antibodies represent a next-generation class of immunotherapies engineered to recognize and bind to two or more different antigens simultaneously. Unlike traditional monoclonal antibodies, which target a single antigen, these multispecific constructs are designed to enhance specificity, functionality, and therapeutic impact — particularly in oncology and immunological disorders.

In oncology, bispecifics have demonstrated potent efficacy by bridging T-cells or NK cells with tumor-associated antigens, leading to direct tumor cell killing. Trispecifics, a further evolution, are engineered to engage multiple immune pathways or target antigens, improving tumor eradication while minimizing immune escape.

Key players such as Akeso, Summit Therapeutics, Roche, Merus, AstraZeneca, and Dren Bio are accelerating innovation in this space. Their therapies are being developed across a wide range of cancers, including Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma, Acute Lymphocytic Leukemia (ALL), Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

As clinical pipelines mature and more approvals emerge, bispecifics and trispecifics are set to redefine targeted treatment strategies, offering more precise and effective options for patients with complex and refractory diseases.

 

Get a free sample for the bispecifics/trispecifics market forecast, size & share analysis report: https://www.delveinsight.com/report-store/bispecifics-trispecifics-competitive-landscape-and-market-forecast

 

Bispecifics/Trispecifics Epidemiology

The epidemiology section of the Bispecifics/Trispecifics report offers detailed historical and forecasted data, segmented by country-specific target populations across the 7MM—comprising the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan—from 2020 to 2035. It includes insights on incident cases by indication, along with eligible and treatable patient populations.

 

Are Bispecific Antibodies Better Than CAR-T Therapies?

While both CAR-T cell therapies and bispecific antibodies have transformed cancer treatment, they differ significantly in efficacy, development focus, and clinical utility. CAR-T therapies have demonstrated strong results in hematological cancers but have yet to show consistent, durable responses in solid tumors. Their complex, patient-specific manufacturing process also presents logistical challenges.

In contrast, bispecific antibodies are showing promising and more durable responses in both hematologic and solid tumors. Currently, there is greater pipeline momentum for bispecifics in solid tumors, while CAR-T development remains largely centered on blood cancers. Additionally, bispecifics are “off-the-shelf” therapies with simpler and more scalable production, giving them a potential edge in accessibility and broader clinical applications.

 

Bispecifics/Trispecifics Drug Class Insights

Bispecific antibodies are redefining cancer treatment, offering targeted, off-the-shelf alternatives to cell therapies. The approval of BLINCYTO (Amgen) marked a major breakthrough for relapsed/refractory B-cell ALL (CD19xCD3), with Amgen now expanding into first-line and chemo-sparing segments, along with a subcutaneous version to enhance long-term utility.

RYBREVANT (J&J) has shown better safety than EXKIVITY in EGFR exon20ins NSCLC and is being tested in 1L with chemo, positioning it to rival TAGRISSO as J&J broadens its reach in EGFR-mutant NSCLC.

Bispecific antibodies—especially T-cell redirecting (TRBAs)—are gaining momentum in trials, leveraging IgG-based formats for prolonged exposure and robust engagement with immune cells. In hematologic malignancies, key targets include CD19, CD20, BCMA, CD123, and CD33, which are often targeted via CD3. Solid tumor bispecifics explore diverse antigen pairings, such as HER2/HER2, VEGF/Ang-2, and PD-1/CTLA-4, reflecting their adaptability in tackling complex tumor biology.

 

Discover how emerging therapies are adapting to shifting patient demographics — download the report for insights into the key factors driving the bispecifics/trispecifics pipeline and evolving epidemiological trends @ Bispecifics/Trispecifics Epidemiology Analysis

 

Bispecifics/Trispecifics Market Outlook

Bispecific antibodies are engineered with two distinct antigen-binding sites, enabling them to engage cancer cells and immune cells simultaneously. Trispecific antibodies, a more recent innovation, extend this approach by incorporating three binding sites, offering enhanced tumor targeting and immune activation. While bispecifics have gained significant traction since their conceptualization in the 1960s—with over 500 candidates in clinical development and multiple FDA approvals—trispecific antibodies are still in early exploration stages, with none yet approved or in late-phase trials.

To date, seven bispecific antibodies have received FDA approval for treating hematologic cancers, including multiple myeloma, acute lymphocytic leukemia, diffuse large B-cell lymphoma (DLBCL), and follicular lymphoma. These therapies primarily function by redirecting T cells (via CD3) to attack tumor cells, targeting antigens like CD19, CD20, BCMA, CD123, and CD33.

In solid tumors, bispecific clinical trials showcase broader antigen diversity and more complex mechanisms of action. This highlights the versatility of bispecific platforms and the growing interest in expanding their potential beyond hematologic indications. As trispecific research advances, the oncology landscape is poised for even greater innovation.

 

Bispecifics/Trispecifics Market Drivers

  • Advances in antibody engineering enhance the efficacy and stability of bispecific/trispecific antibodies for treating hematologic and solid tumors.
  • Bispecific/trispecific antibodies address gaps in treatment for relapsed cancers, expanding their use across multiple indications.

 

Bispecifics/Trispecifics Market Barriers

  • The production of bispecific/trispecific antibodies is complex and costly, limiting accessibility.
  • Immune-related side effects like cytokine release syndrome pose challenges for wider adoption.

 

Scope of the Bispecifics/Trispecifics Market Report

  • Study Period: 2020–2035
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Bispecifics/Trispecifics Companies: AbbVie/Genmab, Roche/Biogen, Pfizer, Amgen, Akeso Biopharma, Summit Therapeutics, SystImmune, Biotheus, Alphamab, Sichuan Baili Pharmaceutical, Regeneron, Merus, Jazz Pharma/Zymeworks, Aurigene Oncology, and others.
  • Key Bispecifics/Trispecifics Therapies: Ivonescimab, Zenocutuzumab, Petosemtamab, Cevostamab, Volrustomig, Rilvegostomig, Lutikizumab, PRV-3279, MEDI-7352, DR-0201, GB263T, CMG1A46, HPN328, and others.
  • Bispecifics/Trispecifics Therapeutic Assessment: Bispecifics/Trispecifics currently marketed, and Bispecifics/Trispecifics emerging therapies
  • Bispecifics/Trispecifics Market Dynamics: Bispecifics/Trispecifics market drivers and Bispecifics/Trispecifics market barriers
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Bispecifics/Trispecifics Unmet Needs, KOL’s views, Analyst’s views, Bispecifics/Trispecifics Market Access and Reimbursement

 

To learn more about bispecifics/trispecifics companies working in the treatment market, visit @ Bispecifics/Trispecifics Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Bispecifics/Trispecifics Market Report Introduction

2. Executive Summary for Bispecifics/Trispecifics

3. SWOT analysis of Bispecifics/Trispecifics

4. Bispecifics/Trispecifics Patient Share (%) Overview at a Glance

5. Bispecifics/Trispecifics Market Overview at a Glance

6. Bispecifics/Trispecifics Disease Background and Overview

7. Bispecifics/Trispecifics Epidemiology and Patient Population

8. Country-Specific Patient Population of Bispecifics/Trispecifics

9. Bispecifics/Trispecifics Current Treatment and Medical Practices

10. Bispecifics/Trispecifics Unmet Needs

11. Bispecifics/Trispecifics Emerging Therapies

12. Bispecifics/Trispecifics Market Outlook

13. Country-Wise Bispecifics/Trispecifics Market Analysis (2020–2035)

14. Bispecifics/Trispecifics Market Access and Reimbursement of Therapies

15. Bispecifics/Trispecifics Market Drivers

16. Bispecifics/Trispecifics Market Barriers

17. Bispecifics/Trispecifics Appendix

18. Bispecifics/Trispecifics Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/competitive-intelligence-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bispecific and Trispecific Antibodies Market Anticipated to Witness Remarkable Expansion by 2035, Says DelveInsight | Leading Players Include Akeso, Summit Therapeutics, Zymeworks, BeiGene, more

Project Roar Publishing Releases Lights, Camera, Lionel Trains! A Photo History of an American Icon, Just in Time for Father’s Day

Winfield, IL – June 10, 2025 – Just in time for Father’s Day, Project Roar Publishing announces the release of Lights, Camera, Lionel Trains! A Photo History of an American Icon, a visually rich coffee-table book celebrating the enduring legacy of Lionel electric trains. Written by award-winning author and model train historian Roger Carp, the 224-page hardcover volume offers a captivating journey through more than a century of American toy train history.

Carp, a seasoned editor and historian with decades of experience chronicling model railroading, brings together 100 photo essays that explore the cultural significance of Lionel trains. From their prominent placement under Christmas trees to their appearances in department store window displays, Lionel trains became deeply rooted in the Americana, as symbols of innovation, joy, and shared family tradition.

“Lionel trains were about more than movement on a track,” says Carp. “They were about memories, moments shared on living room floors, the sparkle of a holiday morning, the joy of building something magical together. They were, and still are, an essential part of our cultural DNA.”

The book showcases more than 220 full-color and black-and-white archival photographs, many of them rare or previously unpublished, from private collections and archives. The collection spans generations, capturing everything from the golden age of postwar toy manufacturing to the hobby’s Hollywood connections.

Lights, Camera, Lionel Trains! dives into the appearances of Lionel sets in popular culture, including scenes in The Godfather, A Christmas Story, I Love Lucy, and Leave It to Beaver. The book also features rarely seen photos of celebrities such as James Cagney, Joe DiMaggio, and Lucille Ball enjoying their Lionel sets, alongside nostalgic images of everyday families captivated by the magic of miniature railroads.

Through detailed photo essays and accompanying commentary, readers get to revisit the height of Lionel trains’ influence during America’s post-war boom, revealing how these model trains became emblems of childhood wonder and adult craftsmanship.

Designed for both collectors and newcomers to the hobby, the book is available in two editions: a standard edition and a limited edition autographed by Roger Carp and the publisher.

Perfect for Father’s Day, Lights, Camera, Lionel Trains! offers a nostalgic journey through American history that’s sure to resonate with dads, grandfathers, and collectors alike.

The book is available for purchase through Amazon and the publisher’s website https://projectroar.com/.

About Roger Carp

Roger Carp is a Lionel trains expert and senior editor at Classic Toy Trains magazine. He has written over 20 books on Lionel’s history and legacy and holds a Ph.D. in American history from the University of North Carolina at Chapel Hill.

About Project Roar Publishing

Founded in 2001, Project Roar Publishing is a publisher dedicated to preserving and sharing the rich history of American toy trains through authoritative books and archival resources. Known for high-quality publications and historical accuracy, Project Roar serves collectors, hobbyists, and historians with a passion for American railroading heritage.

Socials: @projectroar

Media Contact
Company Name: Project Roar Publishing
Contact Person: Jared Kuritz
Email: Send Email
Phone: (760) 550-9850
Country: United States
Website: https://projectroar.com/

Data Center Rack Market 2025 Edition: Industry Size to Reach $9.42 billion by 2030, At a CAGR of 12.7%

“Schneider Electric, HPE, Rittal, Eaton, Vertiv, Dell, Fujitsu, IBM, Cisco, Legrand.”
Data Center Rack Market by Rack Type (Open Frame, Enclosed), Type (Server Racks, Network Racks), Rack Height (42U & Below, 43U up to 52U), Rack Width (19 Inch, 23 Inch), Data Center Type (Enterprise, Colocation, Hyperscale) – Global Forecast to 2030.

The worldwide data center rack market is expected to expand at a compound annual growth rate (CAGR) of 12.7% from USD 5.17 billion in 2025 to USD 9.42 billion by 2030. A data center rack is a piece of hardware used to install servers, networking devices, and other computer equipment in a data center in a neat and practical way. The growing demand for edge computing, high-density computing, and modern architecture is causing a dynamic shift in the data center rack market. Compared to traditional server deployments, modern racks offer superior cable management, airflow control, and support for power and cooling infrastructure.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210971325

Smart rack solutions may also be integrated with DCIM software to monitor power consumption, temperature, and equipment health, enabling timely decision-making and avoiding downtime. These features are particularly valuable in financial, telecom, and cloud operations, where performance and availability are critical to the mission. Remote access is supported by secure methodologies such as encrypted communication, audit trails, and multi-factor authentication to meet stringent compliance requirements. With remote IT administration becoming more prominent in hybrid and edge computing environments, there is an increasing need for intelligent, accessible rack solutions.

Based on services, the support & maintenance segment is expected to grow at highest CAGR during the forecast period

The support and maintenance segment is expected to grow at the highest CAGR during the forecast period. This is because the complexity of data center infrastructure is increasing, and there is a greater need for operational efficiency and high availability. With organizations expanding the capabilities of their data centers to support cloud computing, edge computing, and applications of AI, there is an ever-growing requirement for guaranteed and continuous technical support to minimize downtime and ensure peak rack performance. Support and maintenance offerings include preventive maintenance, hardware diagnostics, software updates, and real-time troubleshooting, critical in maintaining uptime and achieving maximum equipment life.

Furthermore, the rise of remote and hybrid workspaces has increased the reliance on dependable IT infrastructure, leading organizations to invest more in proactive support technologies. Managed service providers and data center companies outsource maintenance services to specialized companies to reduce internal overhead and improve service levels. This trend, combined with the increasing uptake of modular and high-density rack solutions, further highlights the importance of ongoing support and maintenance and is, as such, a prime growth area in the data center rack ecosystem.

Based on rack type, the enclosed segment is expected to hold largest market share during the forecast period.

The enclosed segment will likely maintain the highest market share in the data center rack market through the forecast period based on its increased security, better airflow management, and efficient cooling ability. Enclosed racks, for example, cabinet-style racks, ensure a safe environment for high-end IT equipment as they block unauthorized physical access and safeguard against environmental threats such as dust and debris. The growing demand for scalable, modular, and power-efficient infrastructure in hyperscale and colocation data centers also drives the adoption of enclosed racks. As businesses increasingly depend on cloud services and edge computing, the requirement for more reliable and organized server environments becomes necessary. As the importance of data protection and compliance increases in BFSI and healthcare, sealed racks offer an added layer of physical security.

Based on region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period

Asia Pacific is expected to witness the highest CAGR in the data center rack market during the forecast period, driven by rapid digital transformation, cloud adoption, and rising data consumption across emerging economies. The increasing need for finance, healthcare, and e-commerce drives China, India, Indonesia, and Australia to build new hyperscale and edge data centers.

Government initiatives, such as Digital India and China’s New Infrastructure Plan, enhance infrastructure development, while regulations requiring data to remain local are establishing more data centers in each country. The integration of facilities such as D1 in Darwin with subsea cables significantly enhances connectivity in the region. This development underscores the increasing demand for well-engineered, modular racks to support evolving infrastructure needs. Simultaneously, the rollout of 5G, the increase in AI workflows, and smart city activities based on the Internet of Things are driving interest in large-scale rack systems that run efficiently on low energy. These trends make APAC a major driver in the global data center rack sector.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=210971325

Unique Features in the Data Center Rack Market

Modern data center racks offer modularity, allowing organizations to scale infrastructure easily as per workload demands. These racks support hot-swappable components and customizable configurations, ensuring flexible deployment without major overhauls.

One of the key advancements is the integration of superior airflow designs, such as perforated doors and containment systems. These features help maintain optimal temperature levels, improve energy efficiency, and reduce the need for external cooling systems.

New-generation racks include dedicated cable pathways and management accessories that reduce clutter, minimize signal interference, and improve accessibility during maintenance or upgrades—enhancing both performance and serviceability.

Data center racks are now engineered to handle higher density equipment, including hyper-converged infrastructure and GPU-based computing. This ensures that they can support the processing demands of AI, machine learning, and big data applications.

Major Highlights of the Data Center Rack Market

With the growing need to accommodate more computing power in limited space, high-density racks are gaining traction. These racks support better airflow, cable management, and power distribution, making them ideal for modern hyperscale and enterprise data centers.

The shift towards modular, scalable, and customizable rack solutions is becoming a key trend. Organizations prefer racks that can be tailored to specific needs, support various configurations, and offer ease of integration with evolving technologies like AI, edge computing, and 5G.

The market is seeing widespread adoption across industries such as BFSI, IT & telecom, healthcare, retail, and manufacturing. Each of these sectors is generating vast volumes of data, thereby boosting the demand for efficient rack infrastructure within their data centers.

The growth of hyperscale facilities and the emergence of edge computing are driving demand for versatile rack solutions. Edge data centers, in particular, require compact and ruggedized racks that support remote deployment and efficient thermal management in harsh environments.

Innovations such as smart racks integrated with environmental sensors, power monitoring, and remote management capabilities are reshaping the market. These advancements help improve operational efficiency, ensure uptime, and reduce energy costs.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=210971325

Top Companies in the Data Center Rack Market

Various globally established players, such as Schneider Electric (France), HPE (US), Rittal (Germany), Eaton (Ireland), and Vertiv (US), dominate the market. Major firms have used various strategies to increase their market domination, including partnerships, contracts, mergers and acquisitions, and introducing new products.

Schneider Electric

Schneider Electric is a multinational company based in France that specializes in energy management and automation solutions. Its operations span over 100 countries. The firm offers various products and services to enhance efficiency and sustainability for residential, commercial, and industrial customers. Schneider Electric serves utilities, oil and gas, transportation, and healthcare industries. It is also engaged in smart grid, microgrid, and modular data center initiatives for improving infrastructure resilience and enabling sustainability objectives. Schneider Electric provides data center rack solutions in its APC brand, such as the NetShelter SX and SV series, geared for high-density, scalable, and power-efficient deployments. These enclosures are integrated with the EcoStruxure platform to enable real-time monitoring, enhanced security, and efficient power distribution, serving enterprise, colocation, and edge data center environments. The company also delivers pre-integrated rack systems and micro data centers that support quick installation and remote management in response to evolving demands such as AI workloads, edge computing, and sustainability. With its broad market reach and focus on digital technologies, Schneider Electric supports the development of reliable and adaptable infrastructure for modern data center operations.

HPE

HPE is a global edge-to-cloud technology company that delivers IT infrastructure, high-performance computing, data storage, and cloud services solutions. HPE supports enterprises in accelerating digital transformation through its hardware, software, and as-a-service offerings. HPE’s GreenLake, a hybrid cloud platform offering consumption-based IT across data centers, colocation facilities, and edge locations. It offers its ProLiant server family and integrated rack infrastructure solutions in the data center rack market.

HPE offers pre-configured and custom rack configurations designed to host a range of workloads from core enterprise computing to high-density, AI-based applications. HPE’s partnerships with vendors such as Nexalus for liquid cooling and sustainability activities enhance its value proposition by enabling it to provide increased energy efficiency, reduced carbon impact, and improved thermal management. These racks are optimized to seamlessly integrate with HPE’s computing, storage, and network solutions, providing scalability and simplicity.

Rittal

Rittal GmbH & Co. KG, headquartered in Herborn, Germany, is a leading global provider of IT infrastructure solutions, particularly renowned in the data center rack market. Holding approximately 15% of the global market share, Rittal specializes in modular and scalable rack systems designed to meet the evolving demands of modern data centers, including high-density workloads associated with AI and cloud computing . Their flagship products, such as the VX IT and TX Colo racks, offer flexibility, energy efficiency, and rapid deployment capabilities. Complementing their rack solutions, Rittal provides integrated cooling systems like the Liquid Cooling Package (LCP), intelligent power distribution units (PDUs), and comprehensive monitoring tools, forming a cohesive ecosystem tailored for colocation, enterprise, and hyperscale data centers . Additionally, Rittal collaborates with industry leaders, including Meta, to develop high-power rack solutions compliant with the Open Compute Project (OCP) standards, addressing the increasing power and cooling requirements of next-generation processors.

Eaton

Eaton Corporation plc, headquartered in Dublin, Ireland, is a prominent player in the data center rack market, offering a comprehensive range of solutions tailored for modern data center environments. The company provides modular and scalable rack systems, including the Open Rack v3 (ORV3) compatible solutions developed in collaboration with the Open Compute Project (OCP), aimed at enhancing efficiency and scalability in data centers . Eaton’s SmartRack modular data centers integrate IT racks, cooling, and service enclosures, designed to support critical IT equipment with loads up to 150 kW, facilitating rapid deployment and adaptability to diverse requirements . Additionally, the company’s fourth-generation Rack PDU G4 offers high-security power distribution with features like locking mechanisms and built-in high retention systems, ensuring secure and reliable power management across various data center configurations . Eaton’s strategic focus on innovation and collaboration positions it as a key contributor to the evolving data center infrastructure landscape.

Vertiv

Vertiv, headquartered in Westerville, Ohio, is a leading U.S. provider of critical digital infrastructure solutions, prominently serving the data center rack market. The company offers a diverse portfolio of rack and enclosure systems, including the Vertiv™ VR Rack, designed for high-density environments and supporting a wide range of IT equipment such as servers, storage, and networking devices. Vertiv’s integrated solutions, like SmartAisle and SmartCabinet, combine racks with power, cooling, and monitoring systems, enabling rapid deployment and scalability for various data center configurations. With a global presence and a commitment to innovation, Vertiv continues to support the evolving needs of data centers worldwide.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/data-center-rack-market-210971325.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Data Center Rack Market 2025 Edition: Industry Size to Reach $9.42 billion by 2030, At a CAGR of 12.7%

Blockchain Market Reflects High Growth at 65.5%: Recent Trends, Size, Share, Growth Outlook, Future Scope and Demand Outlook to 2029

“Key Players AWS (US), Oracle (US), IBM (US), Huawei (China), Accenture (Ireland), TCS (India), Google (US), Alibaba (China), Microsoft (US), OVHcloud (France), SAP (Germany), and HPE (US), T Tencent (China), Wipro (India), Infosys (India), Lumen (US), DigitalOcean (US), VMware (US).”
Blockchain Market by Component (Platforms, Services (Managed, Professional)), Provider, Type (Public, Private, Hybrid, Consortium), Deployment Mode (Cloud, On-Premises), Organization Size, Vertical and Region – Global Forecast to 2029.

The global blockchain market is expected to increase at a Compound Annual Growth Rate (CAGR) of 65.5% from 2024 to 2029, from USD 20.1 billion to USD 248.9 billion. The growth of venture capital funds and investments in blockchain technology is driving the technology’s spread.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90100890

Based on the components, platforms to accounts for the highest market size during the forecast period.

The blockchain platform is a decentralized solution used for tracking, documenting, and facilitating transactions. Financial transactions were the initial application of blockchain platforms. But now days, it may be used in many different sectors, such supply chain management and e-commerce. These software programs offer the foundation required to develop apps that depend on any form of transaction. Software programs known as blockchain platforms let companies create blockchain-based apps. The use of a distributed, immutable ledger to record activities, resource movements, and transactions over a network is known as blockchain technology. Businesses can employ a blockchain-based ledger system for any application where transactions are necessary. The blockchain platform operates as a development platform with an integrated distributed ledger-which is an encrypted storage space for all kinds of data. The integrated data is then used to help develop consensus mechanisms that are used to validate and approve transaction.

By vertical, banking and financial services accounts for the highest market size during the forecast period.

Blockchain technology transforms the financial industry by creating a decentralized database of distinct and digital assets. It is simpler to transfer assets using tokens that represent the assets “off-chain” when a distributed ledger is used. Blockchain technology has several advantages for banking, one of which is the creation of tokenized security, which can completely do away with middlemen and reduce asset exchange costs. The application space for banking and financial services has recognized the value of blockchain technology, which aid in the security of consumer transactions. In addition, new business models in payment, online banking, and financial transaction technologies are being made possible by the technological shift from centralized infrastructure management to the distributed ecosystem..

By region, North America accounts for the highest market size.

North America is now the leading region in the global blockchain market due to its abundance of blockchain suppliers. Due to the presence of economically robust nations like the US and Canada, the region offers the most substantial and cutting-edge technological infrastructure. North America is one of the main geographic contributors to the global blockchain market, even when it comes to market size. One of the main factors driving the blockchain market’s growth in North America is the existence of major regional players like IBM, AWS, and others. Businesses in this area are creating blockchain-based solutions to improve customer service. Government agencies are investigating blockchain technology on a number of fronts, including protocols, security assurances, cryptographic techniques, use cases, applications, and current services (National Institute of Standards and Technology, NIST). The study’s conclusions have been documented in academic articles, experimentation software, and suggestions for next NIST projects in this field. Blockchain technology is not limited to manufacturing supply chains; it can also be applied to data registries, digital identities, and record management systems.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=90100890

Unique Features in the Blockchain Market

One of the most distinguishing features of the blockchain market is its decentralized framework. Unlike traditional centralized systems, blockchain operates on a peer-to-peer network where each node maintains a copy of the ledger. This eliminates the need for intermediaries and enhances trust among participants, making transactions transparent and secure without relying on a central authority.

Blockchain ensures data integrity through immutability—once data is written to the blockchain, it cannot be altered or deleted. This creates a reliable and tamper-proof record of transactions, ideal for industries requiring high auditability, such as finance, healthcare, and supply chain. Transparency is further ensured as the entire transaction history is accessible to all network participants.

The integration of smart contracts is a game-changer in the blockchain market. These self-executing contracts automate business processes based on predefined conditions, reducing human intervention and enhancing operational efficiency. Smart contracts are widely used in decentralized finance (DeFi), insurance, and digital identity management.

Blockchain systems use advanced cryptographic techniques to secure transactions and user data. Features such as public/private key encryption, hashing algorithms, and digital signatures provide robust security, minimizing the risks of data breaches, fraud, and unauthorized access.

Major Highlights of the Blockchain Market

The blockchain market is witnessing robust growth driven by increasing investments from venture capital firms, startups, and established enterprises. Governments and financial institutions are also exploring blockchain applications, contributing to market expansion across finance, healthcare, logistics, and beyond. This surge reflects growing confidence in blockchain as a transformative digital infrastructure.

While public blockchains like Bitcoin and Ethereum lead in adoption, hybrid and consortium blockchain models are gaining popularity in enterprise settings. These models offer a balance between transparency and control, enabling collaborative ecosystems in supply chains, banking, and cross-border payments.

Decentralized finance (DeFi) and Web3 technologies are reshaping digital economies by providing open access to financial tools and enabling user ownership of data and digital assets. These innovations are fueling new use cases, including lending, staking, governance, and decentralized applications (dApps), especially across the Ethereum and Solana ecosystems.

Blockchain is increasingly being integrated with other cutting-edge technologies such as Artificial Intelligence (AI), Internet of Things (IoT), and edge computing. These integrations enhance traceability, automation, and real-time decision-making in sectors like smart cities, agriculture, and manufacturing.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=90100890

Top Companies in the Blockchain Market

Key Players AWS (US), Oracle (US), IBM (US), Huawei (China), Accenture (Ireland), TCS (India), Google (US), Alibaba (China), Microsoft (US), OVHcloud (France), SAP (Germany), and HPE (US), T Tencent (China), Wipro (India), Infosys (India), Lumen (US), DigitalOcean (US), VMware (US), Applied Blockchain (UK), ConsenSys (US), Akamai (US), Contabo (Germany), Leewayhertz (US), Vultr (US), Cloudsigma (Switzerland), Mevspace (Poland), and Scaleway (France) are the key players and other players in the blockchain market.

Amazon Web Services (AWS)

Amazon Web Services is a subsidiary of Amazon which provides on-demand cloud computing platforms to individuals, governments, and companies. AWS offers services such storage, computing, networking, database, analytics, application services, deployment, mobile, developer tools, and IoT tools. In blockchain, AWS offers Amazon Managed Blockchain (AMB) Query is a fully managed service that enables organizations to set up and manage a scalable blockchain network smoothly. Amazon Quantum Ledger Database (QLDB) is a fully managed ledger database which enables organizations to easily analyze network activity outside the network and gain insights into trends. The company operates globally with a strong foothold in the Americas, Europe, Middle East & Africa, and Asia Pacific. AWS focuses on expanding its reach in the emerging markets by offering products through regional distributors, channel partners, resellers, service partners, and technology partners.

Oracle

Oracle, is a global provider of enterprise software and cloud solutions. The company provides a comprehensive suite of products and services, including database management, cloud applications, and enterprise software. Oracle’s solutions portfolio extends to ERP, CRM, and supply chain management systems, catering to diverse industries such as finance, healthcare, retail, and manufacturing. Oracle’s Blockchain Platform provides secure, scalable solutions for managing business transactions. With a global presence, Oracle delivers solutions to clients worldwide, driving operational efficiency across various sectors such as automotive, consumer goods, construction and engineering among others.

Huawei

Founded in 1987 by Ren Zhengfei, Huawei is a Chinese multinational corporation headquartered in Shenzhen, Guangdong. The company specializes in designing, developing, and manufacturing a wide range of products, including telecommunications equipment, consumer electronics, smart devices, distributed operating systems, electric vehicle autonomous driving systems, and rooftop solar products. Initially focusing on manufacturing phone switches, Huawei has expanded its operations to over 170 countries, serving more than three billion people worldwide. The company is committed to bringing digital technology to every person, home, and organization for a fully connected, intelligent world. As of 2023, Huawei employed approximately 207,000 people, with 55% of its workforce dedicated to research and development. In 2023, the company invested CNY164.7 billion in R&D, accounting for 23.4% of its total revenue.

Accenture

Accenture is a global multinational professional services company specializing in information technology services and management consulting. Originally part of the Arthur Andersen accounting firm, it became a separate entity in 1989 and rebranded as Accenture in 2001. Headquartered in Dublin, Ireland, Accenture operates in over 52 countries and serves clients worldwide. The company’s services are organized into five main segments: Strategy and Consulting, Technology, Operations, Accenture Song (formerly Interactive), and Industry X. These segments cater to various industries, including communications, media and technology, financial services, health and public service, consumer products, and resources. In the fiscal year 2024, Accenture reported revenues of $64.9 billion and employed approximately 774,000 people globally.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/blockchain-technology-market-90100890.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blockchain Market Reflects High Growth at 65.5%: Recent Trends, Size, Share, Growth Outlook, Future Scope and Demand Outlook to 2029

MRI Systems Market worth US$9.01 billion by 2030 with 6.5% CAGR | MarketsandMarkets™

“he key players profiled in the MRI systems market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan)”
Browse 300 market data Tables and 50 Figures spread through 180 Pages and in-depth TOC on “MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region – Global Forecast to 2030

The global MRI Systems Market, valued at US$6.15 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$6.56 billion in 2025 and an impressive US$9.01 billion by 2030. The market for MRI systems is expected to grow significantly due to the rising burden of diseases, particularly neurological and musculoskeletal conditions, which are projected to increase in the coming years. The growing aging population, along with the increasing prevalence of chronic diseases like cancer, is likely to raise the demand for MRI systems worldwide. Additionally, regulatory support in the form of encouragement for innovations and more favourable reimbursement policies will contribute to the growth of the MRI systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=99

Browse in-depth TOC on “MRI Systems Market“

300 – Tables

50 – Figures

180 – Pages

By Based on field strength, The global MRI systems market is categorized based on field strength into three segments: low-to-mid-field, high & very-high-field, and ultra-high-field MRI systems. The ultra-high-field sector is projected to experience the highest CAGR during the forecast period. Ultra-high-field MRI systems offer a superior signal-to-noise ratio (SNR), which translates into higher-resolution imaging and enhanced contrast. This high sensitivity facilitates an improved visualization of intricate details and pathologies, particularly in neuroimaging applications. As radiologists and healthcare providers increasingly prioritize MRI systems that deliver optimal SNR performance, the demand for ultra-high-field systems is accelerating, positioning it for robust growth.

By on application, the MRI systems market is segmented into brain & neurological MRI, spine & musculoskeletal MRI, pelvic & abdominal MRI, vascular MRI, breast MRI, cardiac MRI, and other applications. The brain & neurological MRI segment accounted for the largest share of the market in 2024 and is also expected to grow at the highest CAGR during the forecast period. The increasing prevalence of neurological disorders—such as stroke, dementia, Parkinson’s disease, and epilepsy—correlates with the significantly growing aging population. These conditions necessitate MRI procedures for precise diagnosis, which is expected to escalate the demand for MRI scans and consequently expand the MRI systems market. The other factors that propel market growth include the introduction of advanced software solutions and the rising integration of high-performance imaging instruments in clinical settings, which also help in segment growth. The advanced software and high-performance imaging instruments ensure.

By end user, the global MRI systems market is categorized according to its end users, which primarily include hospitals, diagnostic imaging centres, and other miscellaneous entities within the healthcare sector. Among these segments, hospitals are projected to dominate the market, holding the largest share in 2024. This trend can be attributed to several factors, including the ongoing expansion of hospital infrastructure, which is designed to accommodate the growing demand for advanced medical imaging technologies. Additionally, hospitals are increasingly equipped with the financial resources necessary to invest in state-of-the-art MRI systems. This financial capability allows them to enhance their diagnostic capabilities and improve patient care, leading to significant growth in the hospital segment of the MRI market. With advancements in technology and increasing patient volumes, this segment is expected to experience robust development in the coming years.

By geography, North America accounted for the largest share of the market in 2024. The growth of this region is characterized by extensive technological innovations supported by a well-established healthcare infrastructure. It is home to key players in the manufacturing and distribution of MRI systems. In the last five years, major developments, expansions, and deals have taken place here. Positive macroeconomic indicators, such as favourable funding scenarios for startups, manufacturing-friendly regulatory frameworks, and strong healthcare spending, have indirectly supported market growth. These factors have contributed to North America acquiring a significant share of the MRI systems market.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=99

The key players profiled in the MRI systems market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US), Esaote S.p.A (Italy), Shanghai United Imaging Healthcare Co., Ltd (China), Aspect Imaging Ltd. (US), and Time Medical Holding (Hong Kong).

Siemens Healthineers (Germany):

Siemens is a leading player in the MRI systems market and is known for its strong portfolio of imaging products. The company operates R&D facilities in Germany, the US, China, and India. Siemens provides diverse products and services, including point-of-care diagnostics, laboratory testing, diagnostic and therapeutic screening, and molecular medicine. With a broad geographic presence, Siemens has a direct footprint in over 70 countries across Europe, the Americas, Asia, Oceania, Africa, and the Middle East. Its primary manufacturing sites are in the US, Germany, and China. The company continually invests in R&D to develop innovative and technologically advanced products. Siemens distributes its products in over 180 countries through various distributors and sales channels.

GE HealthCare (US):

GE HealthCare is headquartered in Illinois, US. The company provides a comprehensive range of products in medical imaging and information technologies, medical diagnostics, disease research, biopharmaceutical manufacturing, drug discovery, and related technologies. Its medical diagnostics and medical imaging portfolio includes various diagnostic solutions, such as molecular imaging, ultrasound, and magnetic resonance imaging technologies. GE HealthCare has a strong global presence, operating in over 140 countries across North America, South America, Europe, the Middle East, the Asia Pacific, and Africa. The company has employed inorganic growth strategies, including acquisitions, to enhance its market position.

Koninklijke Philips N.V. (Netherlands)

Philips is a leader in magnetic resonance imaging, patient monitoring, image-guided therapy, and health informatics. Through its Diagnosis & Treatment segment, Philips offers solutions in diagnostic imaging, image-guided therapy, and ultrasound. The company’s strategy emphasizes product launches and collaborations to enhance its market share. Primarily, Philips pursues inorganic growth strategies, such as agreements and partnerships, to establish a strong position in the imaging market. The company has also invested significantly in research and development for product advancement. Philips operates globally, with 93 production sites in 25 countries and a sales and service network extending to over 100 countries. Key subsidiaries include Philips Medical Systems in Belgium and Philips Electronics India Limited.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/magnetic-resonance-imaging-market-99.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: MRI Systems Market worth US$9.01 billion by 2030 with 6.5% CAGR | MarketsandMarkets™

Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™

“Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland)”
Browse 267 market data Tables and 71 Figures spread through 285 Pages and in-depth TOC on “Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (8mm, 5mm), Setting (Home Care Settings), Application (Glucagon-Like Peptide-1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase) – Global Forecast to 2030

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 and an impressive US$ 3.08 Billion by 2030. The pen needles market has been segmented based on type, length, application, mode of purchase, setting and region. The key factors driving the market growth of the pen needles market include the rising incidence of chronic diseases, favourable reimbursements in certain countries, and decreasing prices of insulin formulations. Factors that provide opportunities for market players include the growing preference for biosimilar drugs, emerging economies to offer high-growth potential, and rising healthcare expenditure on diabetes. Supportive government regulations, such as rigorous safety standards by the US FDA and favourable reimbursement policies, are also expected to fuel the uptake of technologically advanced products. A combination of these factors is expected to facilitate the increased adoption of pen needles in healthcare systems.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613

Browse in-depth TOC on ‘Pen Needles Market’

200 – Tables

80 – Figures

300 – Pages

In this report, the pen needles market has been segmented on the basis of type, length, application, mode of purchase, setting and region.

The pen needles market is segmented into standard pen needles and safety pen needles on the basis of type. Standard pen needles are budget-friendly needles for insulin delivery, which explains their popularity in low-income markets and among the uninsured. These needles are simple and basic, which makes them easier to manufacture. There is no requirement for ultra-thin design or sophisticated coating that is required for more expensive options. Cost is a major determinant in healthcare in developing nations and low-income brackets. With standard pen needles, accessible options for diabetic patients who need insulin therapy are readily available without worry of financial suffocation. Moreover, for the Grey market practioners in developed countries where people do not have insurance, these needles are a cheap and functional alternative. Thus, standard pen needles are vital because they meet minimum requirements of diabetes control which helps increase the availability of insulin delivery worldwide.

The pen needles market is segmented into prescription-based, over the counter (OTC) purchase, online purchase and other modes of purchase on the basis of mode of purchase. Online purchase segment is expected to grow at the highest CAGR during the forecast period of the global pen needles market. As e-commerce grows across the world, the demand for pen needles is also on the rise as new customers are drawn to online shopping. Marketplaces make purchase easier for patients who can now shop for pen needles among other products while sitting in their homes. This is particularly helpful for people with movement disabilities or people living in far flung areas who don’t have a ready access to local pharmacies. Businesses engaged in diabetes care and treatment are benefiting enormously as most e-commerce websites offer better rates, promotions, and subscriptions which aid in controlling diabetes. Furthermore, aspects like covert packaging and home delivery make e-commerce users feel more secure and comfortable. The vast variety of products and brands available in these platforms allows customers more purchasing freedom, which aids in increasing their adoption.

The pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa and GCC Countries on the basis of geographic region. North America holds the largest share of the pen needles market in 2024. North America sees one of the maximum diabetes prevalence rates of the world with the U.S and Canada heads in the top of the insulin-dependent population. As per CDC, more than 37 million Americans suffer from diabetes, and approximately 1.6 million have type 1 diabetes. Thus, Canada also bears a huge burden of diabetes cases with an estimated total of 11.7 million that are affected by diabetes or prediabetes. The prevalence of such patients is relatively high, thus increasing demand for pen needles since it’s the basic need for managing blood glucose. Pen needles require good infrastructure and wide awareness in place with patients desiring easy-to-handle devices such as pen needles, thereby augmenting the uptake of this equipment. Increased concern regarding proper management of diabetes helps in sustaining the demand in the region.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613

Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), ARKRAY, Inc. (Japan), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Medical Devices Inc. (Canada), Montmed, Inc. (Canada), Trividia Health, Inc. (US), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).

EMBECTA CORP. (US)

One of the main products traded by Embecta in the global market is pen needles. The company operates from a US-based facility, as well as having production plants in Ireland and China. The company’s vast range of pen needles, syringes, and safety injection devices is a fundamental factor that helps it withstand competition in global market. Alongside the standard pen needles, the company has a safety pen needle portfolio. The company approaches the growth by both inorganic and organic mechanisms to cement its position in the pen needle market. For instance, on November 2022, Embecta Corporation (US) signed a agreement with Intuity Medical, Inc. (US) under which Embecta sales representatives in the US will promote Intuity Medical’s high-tech POGO automatic blood glucose monitoring system to healthcare professionals.

NOVO NORDISK A/S (DENMARK)

The major source of revenue for the company is its Diabetes and Obesity Care segment. The global diabetes market provides an opportunity for the firm to generate revenues through its Diabetes Care segment. The company obtained approximately 40 million diabetic patients in 2022, from 32 million in 2020.Novo Nordisk is well poised in production with ~16 production sites across five regions and a growing product portfolio, including pen needles. The R&D centers of the company are set up in China, Denmark, India, the UK, and the US. Novo Nordisk increased R&D investments from 13.6% in 2022 to 14.0% in 2023. The company also announced that it would be expanding its presence in the pen needles market through a research hub in the greater Boston metro area, which was announced in March 2023.

B. BRAUN SE (GERMANY)

B. Braun SE is another major player of the pen needle market. In terms of product, the group has a comprehensive presence across geographical boundaries. Also, it has recognition for its branded products, notably Omnican Fine and Omnican Fine Plus injection pen needles. The innovations included in the products such as three facet grinding tip and silicone coating or thin-wall technologies used for injecting pen needles will help the firm obtain a strong presence in branding at the overall markets. The company has a huge geographical presence and subsidiaries in 64 countries. Therefore, it is not dependent on a single market, thus sustaining its leading position. The company intends to focus on new technology and digital transformation for healthcare medical devices.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™

Healthcare Supply Chain Management Market to Hit USD 5.06 Billion by 2030 with 5.3 % CAGR | MarketsandMarkets™

“Oracle (US), SAP SE (Germany), Infor (US), IBM (US), Mckesson Corporation (US), Tecsys Inc. (Canada), Global Healthcare Exchange, LLC. (US), Cardinal Health. (US), Corcentric, Inc. (US), Epicor Software Corporation (US), Coupa. (US), Manhattan Associates (US)”
Browse 538 market data Tables and 62 Figures spread through 528 Pages and in-depth TOC on “Healthcare Supply Chain Management Market by Offering (Suite, Analytics, RFID), Function (Procurement, Sourcing, Order Management, Warehouse, Transportation), Managed (Vaccines, CGT), End User (Medical Devices, Pharma), & Region – Global Forecast to 2030

The global healthcare supply chain management market, valued at US$ 3.51 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$ 3.71 billion in 2024 and an impressive US$ 5.06 billion by 2030. The pressing need for effective and efficient supply chain management in healthcare drives the demand for advanced solutions to tackle supply chain issues. Companies like Oracle, SAP SE, and IBM have devised solutions and services to address all aspects of healthcare supply chain management. There is an increasing need for sophisticated solutions that combine artificial intelligence and machine learning with supply chain management. Hence, numerous companies are focusing on creating AI and ML-driven solutions for supply chain management. Together, these elements drive the growing use of supply chain management solutions in healthcare.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77439622

Browse in-depth TOC on “Healthcare Supply Chain Management Market“

455 – Tables

54 – Figures

386 – Pages

Generative AI is reshaping healthcare supply chain management by offering more accurate, data-driven insights that enable faster and more informed decision-making. Many companies are in charge of using generative AI in supply chain management, solving various challenges while shaping the industry’s future. There are now solutions like IBM Sterling Order and Fulfilment Suite, Manhattan Active Allocation, and Blue Yonder’s Luminate Platform that use AI to manage the supply chain effectively and efficiently.

The global healthcare supply chain management market is segmented into software type, hardware, and services, by offering. The software type segment accounted for the largest share in 2023. The large share of the segment is witnessed due to the growing adoption of advanced software solutions that optimize inventory management, enhance forecasting, and improve decision-making capabilities. These software tools, such as AI-powered platforms, cloud-based systems, and integrated business planning solutions enable the timely access of data, automation of processes, and increase the efficiency of supply chain activities, hence stimulating the demand for these solutions among healthcare organizations. The adoption of supply chain management software also helps improve customer service and communication, enhances decision-making, and minimizes logistical errors in healthcare organizations.

The healthcare supply chain management market is divided into purchasing and inventory management by function. The purchasing management segment is expected to demonstrate the highest growth rate during the forecast period. This growth is driven by healthcare organizations’ need to streamline their procurement processes. Purchasing decisions directly impact a business’s inventory control and management of accurate inventory stock levels to reduce holding costs and ensure inventory levels are replenished promptly. Hence, purchasing management solutions help businesses control expenses, manage vendors more easily, gain visibility into the supply chain, and streamline the purchasing management process.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=77439622

The key players operating in the supply chain management market for healthcare include Oracle (US), SAP SE (Germany), Infor (US), IBM (US), Mckesson Corporation (US), Tecsys Inc. (Canada), Global Healthcare Exchange, LLC. (US), Cardinal Health. (US), Corcentric, Inc. (US), Epicor Software Corporation (US), Coupa. (US), Manhattan Associates (US), Blue Yonder Group, Inc. (US), LogiTag Systems (US), Premier (US), Workday, Inc. (US), Medsphere Systems Corporation (US), Arvato Systems (Germany), and AmerisourceBergen Corporation. (US). These companies have adopted organic & inorganic strategies such as product launches, product updates, expansions, partnerships, collaborations, acquisitions, among others to strengthen their market presence in the healthcare supply chain mangement market.

These players not only have a comprehensive and diverse product portfolio but also a strong geographic presence. Owing to the rapid adoption of supply chain management solutions across various domains of the healthcare industry, these players can focus on technologies and offerings dedicated towards supply management, procurement, inventory management etc.

These market players have offered a diverse range of products and services and have operations worldwide. They rely on technological advancements to avail themselves of innovative products and services and increase their global footprint. These players focus on acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments to expand their global reach and develop innovative healthcare supply chain management solutions.

Oracle is one of the leading providers of enterprise software solutions, offering robust capabilities for healthcare supply chain management solutions leveraging its technological capabilities. The company integrates advanced technologies like AI, machine learning, and IoT to its platforms & solutions to help optimize inventory, streamline procurement, and ensure regulatory compliance in healthcare and life sciences industry. The company offers cloud-based and on-premises solutions designed to improve healthcare organizations’ supply chain operations’ efficiently. It has a broad portfolio of supply chain management tools & services that enable healthcare & life science organizations to improve their operational efficiency while ensuring cost savings. Oracle provides a comprehensive portfolio of cloud solutions for various business functions, including solutions like Oracle product lifecycle management cloud, Oracle supply chain planning cloud, Oracle inventory management cloud, Oracle order management cloud, Oracle order manufacturing cloud, and Oracle logistics cloud, among others. Oracle has a wide geographic presence spanning its operations across North America, Europe, the Middle East, Africa, the Asia Pacific, and South America.

IBM is a prominent provider of healthcare supply chain management (SCM) solutions, leveraging its cutting-edge technologies to address the complexities of the healthcare industry. The supply chain management solutions for healthcare offered by IBM include the IBM Sterling Supply Chain Intelligence Suite, IBM Sterling Order and Fulfilment Suite, among others. The company leverages sophisticated technologies to enhance the strength of its offerings. For instance, its IBM Blockchain for Supply Chain is used for tracking life science & healthcare products like vaccines, medical devices, and pharmaceuticals, reducing the risk of counterfeiting and ensuring regulatory compliance. The company offers its software & solutions to a number of industries, including healthcare, life sciences, FMCG, chemicals and petroleum, electronics, energy and power, among others. The company has a wide geographic presence across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/healthcare-supply-chain-management-market-77439622.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Healthcare Supply Chain Management Market to Hit USD 5.06 Billion by 2030 with 5.3 % CAGR | MarketsandMarkets™